Frontiers in Molecular Neuroscience | Brain Disease Mechanisms

Mini Review

Published on 25 Jun 2024

Downregulation of hsa-miR-132 and hsa-miR-129: non-coding RNA molecular signatures of Alzheimer’s disease

in Brain Disease Mechanisms

Siranjeevi Nagaraj
Carolina Quintanilla-Sánchez
Kunie Ando
Lidia Lopez-Gutierrez
Emilie Doeraene
Andreea-Claudia Kosa
Emmanuel Aydin
Jean-Pierre Brion
Karelle Leroy

Frontiers in Molecular Neuroscience

doi 10.3389/fnmol.2024.1423340

2,780 views
5 citations

Review

Published on 19 Jun 2024

The role of Foxo3a in neuron-mediated cognitive impairment

in Brain Disease Mechanisms

Qin-Qin Liu
Gui-Hua Wu
Xiao-Chun Wang
Xiao-Wen Xiong
Rui-Wang
Bao-Le Yao

Frontiers in Molecular Neuroscience

doi 10.3389/fnmol.2024.1424561

5,773 views
13 citations

Review

Published on 17 Jun 2024

Tackling neurodegeneration in vitro with omics: a path towards new targets and drugs

in Brain Disease Mechanisms

Caterina Carraro
Jessica V. Montgomery
Julien Klimmt
Dominik Paquet
Joachim L. Schultze
Marc D. Beyer

Frontiers in Molecular Neuroscience

doi 10.3389/fnmol.2024.1414886

6,646 views
6 citations

Review

Published on 12 Jun 2024

Mechanisms of inflammation after ischemic stroke in brain-peripheral crosstalk

in Brain Disease Mechanisms

Ling Xie
Ming He
Caidi Ying
Haifeng Chu

Frontiers in Molecular Neuroscience

doi 10.3389/fnmol.2024.1400808

9,333 views
30 citations

Mini Review

Published on 10 Jun 2024

Potential of ferroptosis and ferritinophagy in migraine pathogenesis

in Brain Disease Mechanisms

Michal Fila
Lukasz Przyslo
Marcin Derwich
Jolanta Luniewska-Bury
Elzbieta Pawlowska
Janusz Blasiak

Frontiers in Molecular Neuroscience

doi 10.3389/fnmol.2024.1427815

3,266 views
3 citations

Mini Review

Published on 30 May 2024

Microglia and infiltrating macrophages in ictogenesis and epileptogenesis

in Brain Disease Mechanisms

Sonja Bröer
Alberto Pauletti

Frontiers in Molecular Neuroscience

doi 10.3389/fnmol.2024.1404022

3,647 views
8 citations

Opinion

Published on 28 May 2024

CDGSH iron-sulfur domain 2 as a therapeutic target for stroke: an opinion article

in Brain Disease Mechanisms

Chao-Kang Feng
Wei-Jung Chen
Woon-Man Kung
Yu-Yo Sun
Muh-Shi Lin

Frontiers in Molecular Neuroscience

doi 10.3389/fnmol.2024.1386118

1,503 views

Review

Published on 23 May 2024

Post-stroke cognitive impairment: exploring molecular mechanisms and omics biomarkers for early identification and intervention

in Brain Disease Mechanisms

Qiuyi Lu
Anqi Yu
Juncai Pu
Dawei Chen
Yujie Zhong
Dingqun Bai
Lining Yang

Frontiers in Molecular Neuroscience

doi 10.3389/fnmol.2024.1375973

7,210 views
10 citations

Original Research

Published on 22 May 2024

Adolescent binge ethanol impacts H3K9me3-occupancy at synaptic genes and the regulation of oligodendrocyte development

in Brain Disease Mechanisms

Emily R. Brocato
Rachel Easter
Alanna Morgan
Meenakshi Kakani
Grace Lee
Jennifer T. Wolstenholme

Frontiers in Molecular Neuroscience

doi 10.3389/fnmol.2024.1389100

2,708 views

Original Research

Published on 22 May 2024

Spiral ganglion neuron degeneration in aminoglycoside-deafened rats involves innate and adaptive immune responses not requiring complement

in Brain Disease Mechanisms

Benjamin M. Gansemer
Muhammad T. Rahman
Zhenshen Zhang
Steven H. Green

Frontiers in Molecular Neuroscience

doi 10.3389/fnmol.2024.1389816

4,277 views
4 citations

Original Research

Published on 21 May 2024

Identification of crucial inflammaging related risk factors in multiple sclerosis

in Brain Disease Mechanisms

Mengchu Xu
Huize Wang
Siwei Ren
Bing Wang
Wenyan Yang
Ling Lv
Xianzheng Sha
Wenya Li
Yin Wang

Frontiers in Molecular Neuroscience

doi 10.3389/fnmol.2024.1398665

2,768 views
3 citations

Original Research

Published on 17 May 2024

Dolutegravir induces FOLR1 expression during brain organoid development

in Brain Disease Mechanisms

Carlo Donato Caiaffa
Gabriel Tukeman
Christian Zevallos Delgado
Yogeshwari S. Ambekar
Taye T. Mekonnen
Manmohan Singh
Victoria Rodriguez
Emily Ricco
Daniel Kraushaar
Salavat R. Aglyamov

Frontiers in Molecular Neuroscience

doi 10.3389/fnmol.2024.1394058

4,211 views
11 citations

Original Research

Published on 17 May 2024

Ahnak in the prefrontal cortex mediates behavioral correlates of stress resilience and rapid antidepressant action in mice

in Brain Disease Mechanisms

Dionnet L. Bhatti
Junghee Jin
Jia Cheng
Kathryn McCabe
Ko-Woon Lee
Clara Berdasco
Yu Young Jeong
Subhash C. Sinha
Yong Kim

Frontiers in Molecular Neuroscience

doi 10.3389/fnmol.2024.1350716

3,717 views
1 citation

Original Research

Published on 14 May 2024

Genetic deletion of zinc transporter ZnT3 induces progressive cognitive deficits in mice by impairing dendritic spine plasticity and glucose metabolism

in Brain Disease Mechanisms

Rui Zong
Xiaoding Zhang
Xiaohui Dong
Guan Liu
Jieyao Zhang
Yiting Gao
Zhongyang Zhang
Yiming Ma
Haixia Gao
Nikita Gamper

Frontiers in Molecular Neuroscience

doi 10.3389/fnmol.2024.1375925

3,426 views
3 citations

Editorial

Published on 14 May 2024

Editorial: Women in molecular neuroscience

in Brain Disease Mechanisms

Eva Žerovnik

Frontiers in Molecular Neuroscience

doi 10.3389/fnmol.2024.1422589

1,423 views

Editorial

Published on 08 May 2024

Editorial: 2021 WHO classification of pediatric brain tumors: a final wedding between morphology and molecular biology?

in Brain Disease Mechanisms

Angela Mastronuzzi
Lucia Quaglietta
Elisabetta Schiavello
Andrea Carai

Frontiers in Molecular Neuroscience

doi 10.3389/fnmol.2024.1423298

1,646 views

Mini Review

Published on 02 May 2024

Need of orthogonal approaches in neurological disease modeling in mouse

in Brain Disease Mechanisms

Linda Bossini
Alessandro Sessa

Frontiers in Molecular Neuroscience

doi 10.3389/fnmol.2024.1399953

1,832 views

Original Research

Published on 30 Apr 2024

Caffeine improves mitochondrial dysfunction in the white matter of neonatal rats with hypoxia-ischemia through deacetylation: a proteomic analysis of lysine acetylation

in Brain Disease Mechanisms

Yajun Zhang
Yuqian Wang
Haiping Dou
Shanshan Wang
Danyang Qu
Xin Peng
Ning Zou
Liu Yang

Frontiers in Molecular Neuroscience

doi 10.3389/fnmol.2024.1394886

5,826 views
8 citations

Correction

Published on 26 Apr 2024

Corrigendum: Pediatric CNS tumors and 2021 WHO classification: what do oncologists need from pathologists?

in Brain Disease Mechanisms

Antonio d'Amati
Lavinia Bargiacchi
Sabrina Rossi
Andrea Carai
Luca Bertero
Valeria Barresi
Maria Elena Errico
Anna Maria Buccoliero
Sofia Asioli
Gianluca Marucci

Frontiers in Molecular Neuroscience

doi 10.3389/fnmol.2024.1411360

1,661 views
2 citations

Editorial

Published on 25 Apr 2024

Editorial: The legacy of Dr. Rita Levi-Montalcini: advances in neurotrophic factors in brain disease development and treatment

in Brain Disease Mechanisms

Wei-Jung Chen
Woon-Man Kung
Muh-Shi Lin

Frontiers in Molecular Neuroscience

doi 10.3389/fnmol.2024.1387026

1,811 views

Original Research

Published on 16 Apr 2024

Risk factors and a predictive model for the occurrence of adverse outcomes in patients with new-onset refractory status epilepsy

in Brain Disease Mechanisms

Qiuyan Luo
Rong Lai
Miao Su
Zichao Wu
Huiyu Feng
Hongyan Zhou

Frontiers in Molecular Neuroscience

doi 10.3389/fnmol.2024.1360949

1,804 views
3 citations

Editorial

Published on 15 Apr 2024

Editorial: Molecular and network mechanisms underlying stress resilience

in Brain Disease Mechanisms

Frederick L. Hitti
Brian F. Corbett

Frontiers in Molecular Neuroscience

doi 10.3389/fnmol.2024.1404375

1,324 views

Mini Review

Published on 15 Apr 2024

Targeted protein degradation in CNS disorders: a promising route to novel therapeutics?

in Brain Disease Mechanisms

Sandra Kuemper
Andrew G. Cairns
Kristian Birchall
Zhi Yao
Jonathan M. Large

Frontiers in Molecular Neuroscience

doi 10.3389/fnmol.2024.1370509

14,239 views
14 citations

Original Research

Published on 10 Apr 2024

A novel pathogenic SLC12A5 missense variant in epilepsy of infancy with migrating focal seizures causes impaired KCC2 chloride extrusion

in Brain Disease Mechanisms

Viivi Järvelä
Mira Hamze
Jonna Komulainen-Ebrahim
Elisa Rahikkala
Johanna Piispala
Mika Kallio
Salla M. Kangas
Tereza Nickl
Marko Huttula
Reetta Hinttala

Frontiers in Molecular Neuroscience

doi 10.3389/fnmol.2024.1372662

5,509 views
9 citations

1,099 articles

articles

Downregulation of hsa-miR-132 and hsa-miR-129: non-coding RNA molecular signatures of Alzheimer’s disease

The role of Foxo3a in neuron-mediated cognitive impairment

Tackling neurodegeneration in vitro with omics: a path towards new targets and drugs

Mechanisms of inflammation after ischemic stroke in brain-peripheral crosstalk

Potential of ferroptosis and ferritinophagy in migraine pathogenesis

Microglia and infiltrating macrophages in ictogenesis and epileptogenesis

CDGSH iron-sulfur domain 2 as a therapeutic target for stroke: an opinion article

Post-stroke cognitive impairment: exploring molecular mechanisms and omics biomarkers for early identification and intervention

Adolescent binge ethanol impacts H3K9me3-occupancy at synaptic genes and the regulation of oligodendrocyte development

Spiral ganglion neuron degeneration in aminoglycoside-deafened rats involves innate and adaptive immune responses not requiring complement

Identification of crucial inflammaging related risk factors in multiple sclerosis

Dolutegravir induces FOLR1 expression during brain organoid development

Ahnak in the prefrontal cortex mediates behavioral correlates of stress resilience and rapid antidepressant action in mice

Genetic deletion of zinc transporter ZnT3 induces progressive cognitive deficits in mice by impairing dendritic spine plasticity and glucose metabolism

Editorial: Women in molecular neuroscience

Editorial: 2021 WHO classification of pediatric brain tumors: a final wedding between morphology and molecular biology?

Need of orthogonal approaches in neurological disease modeling in mouse

Caffeine improves mitochondrial dysfunction in the white matter of neonatal rats with hypoxia-ischemia through deacetylation: a proteomic analysis of lysine acetylation

Corrigendum: Pediatric CNS tumors and 2021 WHO classification: what do oncologists need from pathologists?

Editorial: The legacy of Dr. Rita Levi-Montalcini: advances in neurotrophic factors in brain disease development and treatment

Risk factors and a predictive model for the occurrence of adverse outcomes in patients with new-onset refractory status epilepsy

Editorial: Molecular and network mechanisms underlying stress resilience

Targeted protein degradation in CNS disorders: a promising route to novel therapeutics?

A novel pathogenic SLC12A5 missense variant in epilepsy of infancy with migrating focal seizures causes impaired KCC2 chloride extrusion